Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Oct 3 2000
WASHINGTON, DC (Oct. 3, 2000) The Biotechnology Industry Organization (BIO) today reaffirmed that safety is its members’ highest priority and announced...
Sep 29 2000
Washington, D.C. (September 29, 2000) Carl B. Feldbaum, President of the Biotechnology Industry Organization (BIO) issued the following letter to members of...
Sep 27 2000
WASHINGTON, D.C. (September 27, 2000) The Biotechnology Industry Organization (BIO) named U.S. Sen. Richard Lugar (R-Ind.) 1999-2000 Legislator of the Year....
Sep 27 2000
WASHINGTON, D.C. (September 27, 2000) The Biotechnology Industry Organization (BIO) honored U.S. Rep. Bill Thomas (R-Calif.) as 1999-2000 Legislator of the...
Sep 26 2000
WASHINGTON, D.C. (September 26, 2000) (Michael J. Phillips, executive director for food and agriculture of the Biotechnology Industry Organization (BIO)...
Sep 25 2000
September 25, 2000 Dr. Jane E. HenneyCommissionerFood and Drug Administration5600 Fishers LaneRockville, MD 20852 Dear Dr. Henney: As you are aware, over the...
Sep 22 2000
WASHINGTON (September 22, 2000) The Environmental Protection Agency (EPA) reaffirmed Wednesday that a review of all available scientific information indicates...
Sep 22 2000
WASHINGTON, D.C. (September 22, 2000) Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) issued the following statement today on...
Sep 21 2000
WASHINGTON, D.C. (September 21, 2000) The Council for Biotechnology Information (CBI) today announced that Linda Thrane has accepted the position of...


Biotechnology News

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) announces that management will present at the Morgan Stanley Global Healthcare Conference on Wednesday...

September 2, 2014

AUDUBON, Pa.--(BUSINESS WIRE)--Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal implant manufacturer, today announced that Richard Baron, Senior Vice President...

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Aerpio Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today the appointment of Thomas Graney as chief financial officer (CFO) and...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Epizyme, Inc. (NASDAQ: EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with...